8-K current report · filed Oct 13, 2026

Danaher Corporation (DHR) 8-K Current Report: October 13, 2026

Item 5.02Item 8.01DHR overview

Short answer

Danaher Corporation (DHR) filed an 8-K current report with the SEC on October 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events). Board expanded to 13 members with immediate appointments of former CFO Daniel Comas and biotech executive Robert Hershberg.

Danaher Corporation 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Board expanded to 13 members with immediate appointments of former CFO Daniel Comas and biotech executive Robert Hershberg
  • Comas brings Danaher finance, treasury, risk management and corporate development experience, strengthening board-level financial oversight
  • Hershberg joins the Science and Technology Committee, adding pharmaceutical and biotechnology expertise
  • Comas’s consulting agreement terminated September 30, 2026, after compensation of $525,000 in 2025 and $393,750 in 2026
  • Alan Spoon will retire at the 2027 annual meeting, without disagreement with Danaher, creating one board turnover event

Item 8.01 · Other Events

  • Steven and Mitchell Rales waived Founder RSUs covering 500,000 shares each, reducing potential equity dilution
  • Waivers received no consideration, eliminating the associated share-based compensation benefit
  • Founder equity awards remain subject to separate stock-option awards disclosed previously

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Danaher Corporation 8-K filings

Get the next DHR 8-K as it lands

Follow DHR for push alerts, or ask the research agent what this filing means.